Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Study comparing the in-stent responses between bioabsorbable polymer everolimus-eluting stent (BP-EES) and durable polymer everolimus-eluting stent (DP-EES) using coronary angioscopy (CAS) and optical coherence tomography (OCT).

Trial Profile

Study comparing the in-stent responses between bioabsorbable polymer everolimus-eluting stent (BP-EES) and durable polymer everolimus-eluting stent (DP-EES) using coronary angioscopy (CAS) and optical coherence tomography (OCT).

Completed
Phase of Trial: Phase IV

Latest Information Update: 19 Sep 2018

At a glance

  • Drugs Everolimus (Primary)
  • Indications Coronary artery disease; Coronary artery restenosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 Sep 2018 New trial record
    • 29 Aug 2018 Results presented at the ESC Congress 2018: Annual Congress of the European Society of Cardiology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top